Hotline 03-84081983
Facebook Instagram Youtube
  • About
  • Research
  • Product
  • Medical Use
  • MyDerm

MyDerm

Autologous, Bi-layered Tissue Engineered Human Skin (TEHS)

MyDerm®​ – is Malaysia’s first Tissue Engineered Human Skin for the treatment of major skin loss and chronic ulcers. MyDerm® is a fully autologous, bi-layered Tissue Engineered skin constructed using the patient’s own cells engineered in CellTissue’s cGMP certified laboratory.

OUR SOLUTION

A product of 10 years of R&D, MyDerm®​  is a revolutionary 3D autograft skin substitute clinically proven to enhance wound healing and improve surgical outcome. The latest in tissue engineering technology, MyDerm®​ is developed and manufactured in its state-of-the-art cGMP facility to become the ultimate alternative for conventional surgical skin substitute methods.

OUR TECHNOLOGY

MyDerm® is a revolutionary 3D autograft skin substitute that is clinically proven to enhance wound healing and improve surgical outcomes. Developed from a small biopsy of healthy skin harvested from the patient, the product is further processed to isolate skin cells, including keratinocytes and fibroblast cells. These cells are expanded in vitro and used in combination with a fibrin matrix to create a 3D bilayer skin construct that is ready to be transplanted on wounds. MyDerm® works by covering the surface of the wound and acts as an organ transplant with live cells that will assimilate and integrate with the patient’s own body and skin.

WHY MYDERM®​

    • Autologous, so unlikely to cause any rejection or immunological reaction. 
    • Bilayer characteristic in MyDerm® means it mimics the native skin layer of the dermis and epidermis.
    • HDP biomaterial used in MyDerm® production is made of natural molecule which is also autologous and will easily degrade into the body host after implantation
    • Function as a permanent coverage of wound.
    • Able to cover a large wound without the need to harvest from big donor area.
    • Able to restore the barrier function of damaged or burned skin
    • Has the ability to secrete growth factors, enzymes and biochemical to mimic the physiological activity of the skin, hence promote rapid wound healing.
    • Result in better aesthetic outcomes by improving the quality of scarring and pigmentation.

MYDERM®​ CASE STUDY

Before

Day 0

After

Day 93

The patient had a degloving and massive injury due to a sugarcane compressor machine accident. 3 months after undergoing MyDerm® procedure, the wound successfully healed and no need for SSG or amputation after the implantation.

Before

Day 0

After

Day 31

This patient with burn injury involving the medial side of the right lower leg and foot. The patient underwent MyDerm® implantation. After 1-month post-MyDerm® procedure, the wound  healed completely.

Before

Day 0

After

Day 62

The patient with Diabetic Foot ulcer involving the dorsum of left foot underwent wound debridement. The patient underwent MyDerm® implantation. After 2 months post-MyDerm® procedure, the wound was completely healed

Before

Day 0

After

Day 62

22-year-old Malay man, road accident victim with a degloving injury to the right lower leg. MyDerm® was transplanted and achieved 100% wound closure by 2 months

CELL TISSUE TECHNOLOGY SDN BHD

Malaysia's FIRST Tissue Engineering Firm

Established in 2010, Cell Tissue is a Malaysian advanced medical technologybased company, a spin-off of the National University of Malaysia (UKM), one of the country’s leading universities and research institutes.

Cell Tissue is known as Malaysia’s FIRST Tissue Engineering Firm, awarded by the prestigious Malaysian Book of Records in 2016, operated in a certified Current Good Manufacturing Practice (cGMP) laboratory following PIC/S standards by the National Pharmaceutical Regulatory Agency (NPRA), a division of the Ministry of Health Malaysia.

CytoLife & Celllora (1)

FEATURED LINKS

CONNECT WITH US

Facebook Jki-instagram-1-light Youtube

Proudly powered by CTTSB © 2010-2024 Cell Tissue Technology Sdn Bhd, a Universiti Kebangsaan Malaysia spin-off Company. – All rights reserved.